Clinical Trial Update: Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing glufosfamide to best supportive care in metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Glufosfamide (glufosfamide)

Snippet

Sponsor: Threshold Pharmaceuticals | Conditions: Pancreatic Cancer | Phase 3 | Status: COMPLETED